Senti Biosciences Inc
NASDAQ:SNTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Senti Biosciences Inc
NASDAQ:SNTI
|
US |
|
M
|
MindBio Therapeutics Corp
CNSX:MBIO
|
CA |
|
R
|
RoboServer Systems Corp
OTC:RBSY
|
US |
|
A
|
Air Busan Co Ltd
KRX:298690
|
KR |
|
Nam Tai Property Inc
OTC:NTPIF
|
VG |
Balance Sheet
Balance Sheet Decomposition
Senti Biosciences Inc
Senti Biosciences Inc
Balance Sheet
Senti Biosciences Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
31
|
56
|
58
|
36
|
48
|
16
|
|
| Cash Equivalents |
5
|
31
|
56
|
58
|
36
|
48
|
16
|
|
| Short-Term Investments |
13
|
0
|
0
|
41
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
18
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
18
|
2
|
1
|
|
| Other Current Assets |
1
|
1
|
4
|
3
|
18
|
9
|
5
|
|
| Total Current Assets |
19
|
32
|
60
|
103
|
71
|
59
|
23
|
|
| PP&E Net |
17
|
16
|
33
|
75
|
42
|
35
|
24
|
|
| PP&E Gross |
17
|
16
|
33
|
75
|
42
|
35
|
24
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
6
|
10
|
13
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
4
|
6
|
4
|
4
|
|
| Total Assets |
36
N/A
|
48
+35%
|
97
+100%
|
181
+87%
|
119
-34%
|
98
-18%
|
51
-48%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
5
|
2
|
1
|
1
|
3
|
|
| Accrued Liabilities |
3
|
4
|
7
|
15
|
10
|
11
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
2
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
4
|
5
|
15
|
18
|
13
|
13
|
14
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
14
|
13
|
22
|
35
|
40
|
34
|
32
|
|
| Total Liabilities |
18
N/A
|
17
-3%
|
36
+109%
|
54
+47%
|
53
-2%
|
47
-10%
|
46
-3%
|
|
| Equity | ||||||||
| Common Stock |
57
|
90
|
172
|
0
|
0
|
25
|
0
|
|
| Retained Earnings |
40
|
60
|
115
|
173
|
244
|
297
|
359
|
|
| Additional Paid In Capital |
0
|
1
|
4
|
301
|
311
|
323
|
364
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
18
N/A
|
31
+72%
|
60
+95%
|
127
+111%
|
67
-47%
|
51
-24%
|
6
-89%
|
|
| Total Liabilities & Equity |
36
N/A
|
48
+35%
|
97
+100%
|
181
+87%
|
119
-34%
|
98
-18%
|
51
-48%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
4
|
5
|
5
|
31
|
|